The analyst upgraded the stock to "buy" from "hold"
The shares of Tenet Healthcare Corporation (NYSE:THC) up 4% at $41.41 at last check, after Deutsche Bank upgraded the stock to "buy" from "hold," with an added price-target hike to $69 from $28. The firm still sees plenty of upside for the stock, despite its recent rally.
On the charts, THC is nearing its Dec. 10 five-year high of $42.78, where it soared after news that the company is acquiring 45 surgery centers from Surgcenter Development. Currently, the equity is up an impressive 213% since its March lows, and 8.5% year-to-date.
There is still plenty of room for upgrades amongst the brokerage bunch, with nine of the 12 analysts in coverage sporting a "hold" or worse rating on Tenet Healthcare stock. Meanwhile, the 12-month consensus price-target of $38.24 is a 7.4% discount to current levels.
Though short interest has begun to unwind, there is still plenty more to act as a tailwind moving forward. The 6.70 million shares sold short account for 6.5% of the stock's available float, and would take over five days to cover at the security's average pace of trading.
Lastly, now could be a good time to weigh in on THC's next move with options. The stock's Schaeffer's Volatility Index (SVI) of 62% stands higher than just 13% of all other readings in its annual range, implying that options players are pricing in relatively low volatility expectations at the moment.